Global Influenza Vaccine Market Growth 2025-2031

May 2025 | 125 pages | ID: GBB3E8467B24EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.

The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.

Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.

In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.

LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.

This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Analog Vacuum Regulator
• Digital Vacuum Regulator

Segmentation by Application:

• Clinically
• Surgical

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Ohio Medical
• Amico
• Precision Medical
• Air Liquid Healthcare
• Integral
• Allied Healthcare Products
• Shanghai Amcaremed Technology
• Acare
• Hersill

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Vacuum Regulator market?

What factors are driving Medical Vacuum Regulator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Vacuum Regulator market opportunities vary by end market size?

How does Medical Vacuum Regulator break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Influenza Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Influenza Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Influenza Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Influenza Vaccine Segment by Type
  2.2.1 Trivalent Influenza Vaccine
  2.2.2 Quadrivalent Influenza Vaccine
2.3 Influenza Vaccine Sales by Type
  2.3.1 Global Influenza Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Influenza Vaccine Sale Price by Type (2020-2025)
2.4 Influenza Vaccine Segment by Application
  2.4.1 6 Months to 3 Years
  2.4.2 > 3 Years
2.5 Influenza Vaccine Sales by Application
  2.5.1 Global Influenza Vaccine Sale Market Share by Application (2020-2025)
  2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Influenza Vaccine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Influenza Vaccine Breakdown Data by Company
  3.1.1 Global Influenza Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global Influenza Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Influenza Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global Influenza Vaccine Revenue by Company (2020-2025)
  3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution
  3.4.2 Players Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INFLUENZA VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Influenza Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Influenza Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Influenza Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Influenza Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global Influenza Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Influenza Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Influenza Vaccine Sales Growth
4.4 APAC Influenza Vaccine Sales Growth
4.5 Europe Influenza Vaccine Sales Growth
4.6 Middle East & Africa Influenza Vaccine Sales Growth

5 AMERICAS

5.1 Americas Influenza Vaccine Sales by Country
  5.1.1 Americas Influenza Vaccine Sales by Country (2020-2025)
  5.1.2 Americas Influenza Vaccine Revenue by Country (2020-2025)
5.2 Americas Influenza Vaccine Sales by Type (2020-2025)
5.3 Americas Influenza Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Influenza Vaccine Sales by Region
  6.1.1 APAC Influenza Vaccine Sales by Region (2020-2025)
  6.1.2 APAC Influenza Vaccine Revenue by Region (2020-2025)
6.2 APAC Influenza Vaccine Sales by Type (2020-2025)
6.3 APAC Influenza Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Influenza Vaccine by Country
  7.1.1 Europe Influenza Vaccine Sales by Country (2020-2025)
  7.1.2 Europe Influenza Vaccine Revenue by Country (2020-2025)
7.2 Europe Influenza Vaccine Sales by Type (2020-2025)
7.3 Europe Influenza Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Influenza Vaccine by Country
  8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Influenza Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Influenza Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Vaccine
10.3 Manufacturing Process Analysis of Influenza Vaccine
10.4 Industry Chain Structure of Influenza Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Influenza Vaccine Distributors
11.3 Influenza Vaccine Customer

12 WORLD FORECAST REVIEW FOR INFLUENZA VACCINE BY GEOGRAPHIC REGION

12.1 Global Influenza Vaccine Market Size Forecast by Region
  12.1.1 Global Influenza Vaccine Forecast by Region (2026-2031)
  12.1.2 Global Influenza Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Influenza Vaccine Forecast by Type (2026-2031)
12.7 Global Influenza Vaccine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Influenza Vaccine Product Portfolios and Specifications
  13.1.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 CSL
  13.2.1 CSL Company Information
  13.2.2 CSL Influenza Vaccine Product Portfolios and Specifications
  13.2.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 CSL Main Business Overview
  13.2.5 CSL Latest Developments
13.3 GSK
  13.3.1 GSK Company Information
  13.3.2 GSK Influenza Vaccine Product Portfolios and Specifications
  13.3.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 GSK Main Business Overview
  13.3.5 GSK Latest Developments
13.4 Viatris
  13.4.1 Viatris Company Information
  13.4.2 Viatris Influenza Vaccine Product Portfolios and Specifications
  13.4.3 Viatris Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Viatris Main Business Overview
  13.4.5 Viatris Latest Developments
13.5 AstraZeneca
  13.5.1 AstraZeneca Company Information
  13.5.2 AstraZeneca Influenza Vaccine Product Portfolios and Specifications
  13.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 AstraZeneca Main Business Overview
  13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
  13.6.1 Hualan Bio Company Information
  13.6.2 Hualan Bio Influenza Vaccine Product Portfolios and Specifications
  13.6.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Hualan Bio Main Business Overview
  13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
  13.7.1 Changchun Institute of Biological Company Information
  13.7.2 Changchun Institute of Biological Influenza Vaccine Product Portfolios and Specifications
  13.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Changchun Institute of Biological Main Business Overview
  13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
  13.8.1 Sinovac Company Information
  13.8.2 Sinovac Influenza Vaccine Product Portfolios and Specifications
  13.8.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Sinovac Main Business Overview
  13.8.5 Sinovac Latest Developments
13.9 BCHT
  13.9.1 BCHT Company Information
  13.9.2 BCHT Influenza Vaccine Product Portfolios and Specifications
  13.9.3 BCHT Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 BCHT Main Business Overview
  13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
  13.10.1 Jiangsu GDK Company Information
  13.10.2 Jiangsu GDK Influenza Vaccine Product Portfolios and Specifications
  13.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Jiangsu GDK Main Business Overview
  13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
  13.11.1 KM Biologics Company Information
  13.11.2 KM Biologics Influenza Vaccine Product Portfolios and Specifications
  13.11.3 KM Biologics Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 KM Biologics Main Business Overview
  13.11.5 KM Biologics Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Influenza Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Influenza Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Influenza Vaccine Sales by Type (2020-2025) & (M Units)
Table 6. Global Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Influenza Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Influenza Vaccine Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Influenza Vaccine Sale by Application (2020-2025) & (M Units)
Table 11. Global Influenza Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Influenza Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Influenza Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Influenza Vaccine Sales by Company (2020-2025) & (M Units)
Table 16. Global Influenza Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Influenza Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Influenza Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Influenza Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Influenza Vaccine Products Offered
Table 22. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Influenza Vaccine Sales by Geographic Region (2020-2025) & (M Units)
Table 26. Global Influenza Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Influenza Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Influenza Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Influenza Vaccine Sales by Country/Region (2020-2025) & (M Units)
Table 30. Global Influenza Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Influenza Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Influenza Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Influenza Vaccine Sales by Country (2020-2025) & (M Units)
Table 34. Americas Influenza Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Influenza Vaccine Sales by Type (2020-2025) & (M Units)
Table 37. Americas Influenza Vaccine Sales by Application (2020-2025) & (M Units)
Table 38. APAC Influenza Vaccine Sales by Region (2020-2025) & (M Units)
Table 39. APAC Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Influenza Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Influenza Vaccine Sales by Type (2020-2025) & (M Units)
Table 42. APAC Influenza Vaccine Sales by Application (2020-2025) & (M Units)
Table 43. Europe Influenza Vaccine Sales by Country (2020-2025) & (M Units)
Table 44. Europe Influenza Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Influenza Vaccine Sales by Type (2020-2025) & (M Units)
Table 46. Europe Influenza Vaccine Sales by Application (2020-2025) & (M Units)
Table 47. Middle East & Africa Influenza Vaccine Sales by Country (2020-2025) & (M Units)
Table 48. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Influenza Vaccine Sales by Type (2020-2025) & (M Units)
Table 50. Middle East & Africa Influenza Vaccine Sales by Application (2020-2025) & (M Units)
Table 51. Key Market Drivers & Growth Opportunities of Influenza Vaccine
Table 52. Key Market Challenges & Risks of Influenza Vaccine
Table 53. Key Industry Trends of Influenza Vaccine
Table 54. Influenza Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Influenza Vaccine Distributors List
Table 57. Influenza Vaccine Customer List
Table 58. Global Influenza Vaccine Sales Forecast by Region (2026-2031) & (M Units)
Table 59. Global Influenza Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Influenza Vaccine Sales Forecast by Country (2026-2031) & (M Units)
Table 61. Americas Influenza Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Influenza Vaccine Sales Forecast by Region (2026-2031) & (M Units)
Table 63. APAC Influenza Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Influenza Vaccine Sales Forecast by Country (2026-2031) & (M Units)
Table 65. Europe Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Influenza Vaccine Sales Forecast by Country (2026-2031) & (M Units)
Table 67. Middle East & Africa Influenza Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Influenza Vaccine Sales Forecast by Type (2026-2031) & (M Units)
Table 69. Global Influenza Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Influenza Vaccine Sales Forecast by Application (2026-2031) & (M Units)
Table 71. Global Influenza Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Influenza Vaccine Product Portfolios and Specifications
Table 74. Sanofi Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Influenza Vaccine Product Portfolios and Specifications
Table 79. CSL Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CSL Main Business
Table 81. CSL Latest Developments
Table 82. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Influenza Vaccine Product Portfolios and Specifications
Table 84. GSK Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Viatris Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Viatris Influenza Vaccine Product Portfolios and Specifications
Table 89. Viatris Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Viatris Main Business
Table 91. Viatris Latest Developments
Table 92. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Influenza Vaccine Product Portfolios and Specifications
Table 94. AstraZeneca Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Hualan Bio Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Hualan Bio Influenza Vaccine Product Portfolios and Specifications
Table 99. Hualan Bio Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Hualan Bio Main Business
Table 101. Hualan Bio Latest Developments
Table 102. Changchun Institute of Biological Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Changchun Institute of Biological Influenza Vaccine Product Portfolios and Specifications
Table 104. Changchun Institute of Biological Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Changchun Institute of Biological Main Business
Table 106. Changchun Institute of Biological Latest Developments
Table 107. Sinovac Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Influenza Vaccine Product Portfolios and Specifications
Table 109. Sinovac Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. BCHT Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. BCHT Influenza Vaccine Product Portfolios and Specifications
Table 114. BCHT Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. BCHT Main Business
Table 116. BCHT Latest Developments
Table 117. Jiangsu GDK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu GDK Influenza Vaccine Product Portfolios and Specifications
Table 119. Jiangsu GDK Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Jiangsu GDK Main Business
Table 121. Jiangsu GDK Latest Developments
Table 122. KM Biologics Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Influenza Vaccine Product Portfolios and Specifications
Table 124. KM Biologics Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Influenza Vaccine
Figure 2. Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Vaccine Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Influenza Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Influenza Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Influenza Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Influenza Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Trivalent Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Influenza Vaccine Sales Market Share by Type in 2025
Figure 14. Global Influenza Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Influenza Vaccine Consumed in 6 Months to 3 Years
Figure 16. Global Influenza Vaccine Market: 6 Months to 3 Years (2020-2025) & (M Units)
Figure 17. Influenza Vaccine Consumed in > 3 Years
Figure 18. Global Influenza Vaccine Market: > 3 Years (2020-2025) & (M Units)
Figure 19. Global Influenza Vaccine Sale Market Share by Application (2024)
Figure 20. Global Influenza Vaccine Revenue Market Share by Application in 2025
Figure 21. Influenza Vaccine Sales by Company in 2025 (M Units)
Figure 22. Global Influenza Vaccine Sales Market Share by Company in 2025
Figure 23. Influenza Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Influenza Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Influenza Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Influenza Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Influenza Vaccine Sales 2020-2025 (M Units)
Figure 28. Americas Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Influenza Vaccine Sales 2020-2025 (M Units)
Figure 30. APAC Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Influenza Vaccine Sales 2020-2025 (M Units)
Figure 32. Europe Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Influenza Vaccine Sales 2020-2025 (M Units)
Figure 34. Middle East & Africa Influenza Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Influenza Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 38. Americas Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Influenza Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Influenza Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 46. APAC Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Influenza Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Influenza Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 57. Europe Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. France Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Influenza Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Influenza Vaccine
Figure 73. Industry Chain Structure of Influenza Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Influenza Vaccine Sales Market Forecast by Region (2026-2031)
Figure 76. Global Influenza Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Influenza Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Influenza Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Influenza Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Influenza Vaccine Revenue Market Share Forecast by Application (2026-2031)